Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma
- Conditions
- Multiple MyelomaInfection
- Interventions
- Drug: Standard myeloma treatmentDrug: Observation
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2015-12-08
- Lead Sponsor
- Henrik Gregersen
- Target Recruit Count
- 300
- Registration Number
- NCT02624440
- Locations
- 🇩🇰
Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
🇩🇰Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
🇩🇰Department of Hematology, Rigshospitalet, Copenhagen, Denmark
Clarithromycin in Multiple Myeloma Induction Therapy
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2015-10-12
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- Henrik Gregersen
- Target Recruit Count
- 58
- Registration Number
- NCT02573935
- Locations
- 🇩🇰
Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
🇩🇰Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
🇩🇰Department of Hematology, Rigshospitalet, Copenhagen, Denmark
Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support
- Conditions
- Multiple Myeloma
- Interventions
- Drug: Induction with CAR-CY-DEX and conditioning with carfilzomib and highdose melphalanDrug: Carfilzomib/dexamethasone maintenanceDrug: Observation without carfilzomib/dexamethasone maintenance
- First Posted Date
- 2015-10-09
- Last Posted Date
- 2018-08-17
- Lead Sponsor
- Henrik Gregersen
- Target Recruit Count
- 200
- Registration Number
- NCT02572492
- Locations
- 🇩🇰
Aalborg University Hospital, Aalborg, Denmark
🇫🇮Turku University Hospital, Turku, Finland
🇱🇹Vilnius University hospital "Santariskiu Clinics", Vilnius, Lithuania
Microdose Study of Melphalan, Bortezomib and Dexamethasone
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2015-12-08
- Lead Sponsor
- Henrik Gregersen
- Target Recruit Count
- 6
- Registration Number
- NCT02109861
- Locations
- 🇩🇰
Department of Haematology, Aalborg University Hospital, Aalborg, Denmark